What does Beyond Air, Inc. do?
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung…
What is Beyond Air, Inc.'s P/E and P/B ratio?
Beyond Air, Inc. has a P/E ratio of -0.0 and a P/B ratio of 1.13.
What is Beyond Air, Inc.'s debt-to-equity ratio?
Beyond Air, Inc. has a debt-to-equity ratio of 8.31.
How much does Beyond Air, Inc. owe compared with what it owns?
Beyond Air, Inc. owes $0.91 for every $1 it owns (balance sheet Jun 2026), which is high.
What is Beyond Air, Inc.'s Positivity rank?
Beyond Air, Inc. is ranked #5,915 of 6,774 companies globally and #3,313 of 4,000 in United States on PositoAI, with a Positivity Score of 14,011.
Does Beyond Air, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Beyond Air, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 10 Apr 2026). It has no yellow flags.
Where can I read the latest news about Beyond Air, Inc.?
Recent headlines about Beyond Air, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Beyond Air, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Beyond Air, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.